SCHEMBL8439895

SCHEMBL8439895

O=C(O)c1ccc(C(=O)c2cccs2)cc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGDS O60760 1/20 0.78
HPGD P15428 6/20 0.70
HTT P42858 1/20 0.70
DAO P14920 1/20 0.63
CYP2C9 P11712 2/20 0.63
LMNA P02545 2/20 0.63
ALDH1A1 P00352 2/20 0.63
PTGS1 P23219 2/20 0.63
PTGS2 P35354 2/20 0.63
KDM4E B2RXH2 1/20 0.63
RXFP1 Q9HBX9 1/20 0.63
ALOX15 P16050 1/20 0.59
NPC1 O15118 3/20 0.58
RAB9A P51151 3/20 0.58
TSHR P16473 1/20 0.58
TP53 P04637 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
MAPT P10636 2/20 0.55
SRD5A2 P31213 2/20 0.54
CES2 O00748 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6793430 0.92 HPGDS (0.83) HPGDSHPGDHTTDAOCYP2C9
SCHEMBL158020 0.88 HPGDS (1.00) HPGDSHPGDHTTDAOCYP2C9
Water SCHEMBL28007578 0.86 HPGDS (0.96) HPGDSHPGDHTTDAOCYP2C9
SCHEMBL7485708 0.84 HPGDS (0.71) HPGDSHPGDHTTDAOCYP2C9
SCHEMBL18906076 0.83 HPGDS (0.70) HPGDSHPGDHTTDAOCYP2C9
SCHEMBL5591866 0.82 HPGDS (0.69) HPGDSHPGDHTTCYP2C9LMNA
SCHEMBL6326690 0.82 HPGD (1.00) HPGDSHPGDHTTDAOCYP2C9
SCHEMBL2760408 0.82 HPGDS (0.69) HPGDSHPGDHTTCYP2C9LMNA
SCHEMBL11306574 0.82 HPGDS (0.69) HPGDSHPGDHTTDAOCYP2C9
SCHEMBL4420563 0.82 HPGDS (0.69) HPGDSHPGDHTTDAOCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170152443-A1 LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT CHI MEI CORPORATION (TW) 2017-06-01 US disclosed
US-20170152443-A1 LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT CHI MEI CORPORATION (TW) 2017-06-01 US disclosed
US-5998433-A THERAPY FOR HYPERLIPIDEMIA; ATHEROSCLEROSIS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-12-07 US disclosed
CN-1160403-A Substd. heterobicyclic alkyl amines and their use as squalene oxide cyclase inhibitors TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1997-09-24 CN disclosed
EP-0785939-A1 SUBSTITUTED HETEROBICYCLIC ALKYL AMINES AND THEIR USE AS SQUALENE OXIDE CYCLASE INHIBITORS Takeda Chemical Industries, Ltd. (JP) 1997-07-30 EP disclosed
WO-1996011201-A1 SUBSTITUTED HETEROBICYCLIC ALKYL AMINES AND THEIR USE AS SQUALENE OXIDE CYCLASE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-04-18 WO disclosed